Document Detail


Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial.
MedLine Citation:
PMID:  17662577     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Prepulse inhibition (PPI), whereby the startle eyeblink response is inhibited by a relatively weak non-startling stimulus preceding the powerful startle eliciting stimulus, is a measure of sensorimotor gating and has been shown to be deficient in schizophrenia patients. There is considerable interest in whether conventional and/or atypical antipsychotic medications can "normalize" PPI deficits in schizophrenia patients. 51 schizophrenia patients participated in a randomized, double-blind controlled trial on the effects of three commonly-prescribed antipsychotic medications (risperidone, olanzapine, or haloperidol) on PPI, startle habituation, and startle reactivity. Patients were tested at baseline, Week 4 and Week 8. Mixed model regression analyses revealed that olanzapine significantly improved PPI from Week 4 to Week 8, and that at Week 8 patients receiving olanzapine produced significantly greater PPI than those receiving risperidone, but not haloperidol. There were no effects of medication on startle habituation or startle reactivity. These results support the conclusion that olanzapine effectively increased PPI in schizophrenia patients, but that risperidone and haloperidol had no such effects. The results are discussed in terms of animal models, neural substrates, and treatment implications.
Authors:
Jonathan K Wynn; Michael F Green; Joyce Sprock; Gregory A Light; Clifford Widmark; Christopher Reist; Stephen Erhart; Stephen R Marder; Jim Mintz; David L Braff
Related Documents :
852367 - Mood elevating effect of trihexyphenidyl and biperiden in individuals taking antipsycho...
14671877 - Atypical and conventional depot medications.
16169527 - Neurological abnormalities in schizophrenic twins.
21062617 - Challenges and solutions in developing new medications for schizophrenia.
17003537 - Genetics and congenital malformations: interpretations, attitudes and practices in subu...
1652747 - The effect of medical therapy on dentin formation in vitamin d-resistant rickets.
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2007-07-26
Journal Detail:
Title:  Schizophrenia research     Volume:  95     ISSN:  0920-9964     ISO Abbreviation:  Schizophr. Res.     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-09-03     Completed Date:  2007-10-24     Revised Date:  2011-08-18    
Medline Journal Info:
Nlm Unique ID:  8804207     Medline TA:  Schizophr Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  134-42     Citation Subset:  IM    
Affiliation:
Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA. jkwynn@ucla.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acoustic Stimulation
Antipsychotic Agents / therapeutic use*
Benzodiazepines / pharmacology,  therapeutic use
Double-Blind Method
Electromyography
Female
Habituation, Psychophysiologic / drug effects*
Haloperidol / pharmacology,  therapeutic use
Humans
Male
Middle Aged
Psychotic Disorders / drug therapy,  psychology
Risperidone / pharmacology,  therapeutic use
Schizophrenia / drug therapy*
Schizophrenic Psychology
Startle Reaction / drug effects*
Treatment Outcome
Grant Support
ID/Acronym/Agency:
MH-042228/MH/NIMH NIH HHS; R01 MH042228-18/MH/NIMH NIH HHS
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 106266-06-2/Risperidone; 12794-10-4/Benzodiazepines; 132539-06-1/olanzapine; 52-86-8/Haloperidol
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Combined transdermal scopolamine and botulinum toxin A to treat a parotid fistula after a face-lift ...
Next Document:  Tobacco smoking in Egyptian schizophrenia patients with and without obsessive-compulsive symptoms.